Delivery Order SPE2DB22D1106-SPE2DB24FFBZ1

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cervidil 10 mg vaginal inserts. The ceiling value of the delivery order is $1,211.20, with a completion date of May 16, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CERVIDIL 10 MG VAGINAL INSERTS to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide in support of the...
This federal contract award is for the delivery of Cervidil 10 mg vaginal inserts, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,149.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of CERVIDIL 10 MG vaginal inserts. The contract has a ceiling value of $3,743.64 and an ultimate completion date of May 9, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $6,239.40, to AmerisourceBergen Drug Corp for the supply of CERVIDIL 10 MG vaginal inserts. This order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen Drug Corp, a subsidiary of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cervidil 10 mg vaginal inserts. The award, with a ceiling value of $1,499.70, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a wide...
This federal contract award, valued at $5,303.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Cervidil 10 mg vaginal inserts, a pharmaceutical product, with a period of performance extending to May 14, 2024. Amerisourcebergen, a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,955.84 firm fixed-price delivery order is for the supply of CERVIDIL 10 MG vaginal inserts. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,919.06, is for the delivery of CERVIDIL 10 MG VAGINAL INSRTS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of January 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 10 mg vaginal inserts of the drug CERVIDIL, with a contract ceiling value of $2,030.64 and a period of performance through February 5, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFBZ1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cervidil 10 mg vaginal inserts. The contract is a Delivery Order with a Firm Fixed Price ceiling value of $6,239.40 and a completion date of July 16, 2024. Amerisourcebergen, through its Corporate Office division, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. This specific contract award is not designated as a set-aside.

Generated 10/14/24, 10:13 AM